Navigation Links
Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
Date:6/7/2011

single primary site in more than 90 percent of the cases, and provided a more objective and informative diagnosis to physicians.

Finally, in collaboration with a group of international clinicians, bioTheranostics presented data from a study evaluating the utility of a novel P95 assay. The study assessed the assay's ability to identify the truncated form of the Her2 gene in Her2-positive breast cancer patients as a means to predict trastuzumab response.

About bioTheranostics

Advancing Molecular Diagnostics in Oncology

bioTheranostics discovers, develops and commercializes molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling and algorithm development, bioTheranostics provides innovative tests to the oncology community. The company operates a CLIA-certified, CAP-accredited diagnostic service laboratory in San Diego, CA to perform its proprietary molecular diagnostic tests: Breast Cancer Index(SM), which is a prognostic test that provides quantitative risk assessment of distant recurrence in patients diagnosed with estrogen receptor positive and lymph node negative breast cancer; and the CancerTYPE ID® test, which uses the differential expression of 92 genes to aid in the determination of tumor site of origin. For more information call 1-858-587-5870 or visit www.bioTheranostics.com.

About bioMerieux

Advancing Diagnostics to Improve Public Health

A world leader in the field of in vitro diagnostics for over 45 years, bioMerieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2010, revenues reached €1.357 billion with 87% of sales outside of France.

bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer
'/>"/>

SOURCE bioTheranostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tocagens First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma
2. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
3. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
4. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
5. Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials
6. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
7. Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing
8. IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment
9. Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase
10. PLC Ramps Up for U.S. Clinical Trial of RenalGuard®
11. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... /CNW/ - The issue: Health ... at Art Nails Ltd., located at 751 Helmcken St., ... contained no labelling. All products administered by injection in ... have approved labelling. The store owner claimed ... risks associated with injecting an unauthorized version of a health product ...
(Date:3/3/2015)... , March 3, 2015   ... and 240 patients respectively Publications in peer ... of Clinical Gastroenterology highlight diagnostic value of confocal ... China and across Asia ... Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) ... Diagnostics Market 2015-2019" report to their offering. ... Diagnostics market to grow at a CAGR of 8.47 ... diagnostics are IVD devices and tools used for diagnosing ... use of these devices helps in the rapid diagnosis ...
Breaking Medicine Technology:Advisory - Health product seized from Art Nails in Vancouver 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
... Inc.,(Nasdaq: ITMN ) today announced that it ... pirfenidone in idiopathic pulmonary fibrosis (IPF) prior,to market open ... conference,call and webcast, with accompanying slide presentation, to discuss ... a.m. PST) on Tuesday,February 3. , ...
... led by Laurie Ozelius, Ph.D. at Mount Sinai School ... development of primary torsion dystonia, also known as DYT6 ... Research Foundation (DMRF), Dr. Ozelius and her colleagues have ... dystonia in Amish-Mennonite families, as well as in other ...
Cached Medicine Technology:InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder 2
(Date:3/3/2015)... New York, NY (PRWEB) March 03, 2015 ... sleepy this spring. Sanjeev Kothare, MD, has tips for parents. ... tired come March 8 at 2:00 a.m. when they set ... because when you wake up that day -- one hour ... sleep. , That’s why parents should start thinking about “sleep ...
(Date:3/3/2015)... Sunday, March 1, through Saturday, March 7, ... of year, every region of the country is at risk ... Amica Insurance is sharing the following tips from the ... keep you safe in the event of severe weather: , ... clothing frequently to prevent loss of body heat. Wear warm, ...
(Date:3/3/2015)... 2015 -- vRad ( Virtual Radiologic ), the nation’s ... Arlene Sussman, MD, a highly regarded breast imaging and ... explore how telemedicine best practices allow for the access ... virtually anywhere. Click here to register for ... 4, 2015 at 1:00 pm CT. , Hospitals must ...
(Date:3/3/2015)... March 03, 2015 Splashtop Inc. ... announces Mirroring360 is now available for Epson® MoverioTM BT-200 ... the Moverio Apps Market , iPod, iPhone, and ... experience to the Epson Moverio smart glasses using Mirroring360, ... , The Epson smart glasses have an ...
(Date:3/3/2015)... 2015 According to a new ... market saturation has made neurosurgery navigation system procedures ... States. Unit sales growth moderately increased in 2014, ... replace older systems, and as new technology becomes ... very much a replacement and upgrade market,” explains ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3
... ... Certified® 2011with Five Stars for Usability. , ... New York, NY (PRWEB) April 25, 2010 -- CureMD Corporation, ... and revenue cycle service, announced today that CureMD EHR V10 has earned its designation ...
... INDIANAPOLIS Less than a quarter of Americans want no ... the president last month but there may be more common ... latest national survey by researchers from Indiana University,s Center for ... respondents were asked how they viewed the new law:, ...
... ... , ... -- In a recent issue of March 19 India abroad featured Dr. Rajesh Khanna, ... Refractive Surgery. In the article India Abroad praised Khanna for his considerable success in the ...
... ... Task Force to explore possible impacts of desalination in the Arabian Gulf and make ... Steering Committee as well as dates for the upcoming Environmental Symposium in Bahrain. ... (PRWEB) April 24, ...
... ... star for her work on behalf of Parkinson,s research , ... East Islip, NY (PRWEB) April 24, 2010 -- The ... and a person afflicted by the disease who have come together to find a cure at ...
... ... ... 2010 -- It,s a fact that older people have sex. It,s also a fact that ... school when they were growing up. With the advent of male enhancement medications, an increase ...
Cached Medicine News:Health News:CureMD EHR V10 CCHIT Certified 2011with Five Stars for Usability 2Health News:More common ground in health care reform law disagreement than meets the eye 2Health News:India Abroad Features Americas Top Ophthalmologist Rajesh Khanna 2Health News:India Abroad Features Americas Top Ophthalmologist Rajesh Khanna 3Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 2Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 3Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 4Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 5Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 6Health News:International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium 7Health News:Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner 2Health News:Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner 3Health News:JustGetTested.com Recommends Confidential Blood Testing During Sexually Transmitted Disease (STD) Awareness Month (April) 2Health News:JustGetTested.com Recommends Confidential Blood Testing During Sexually Transmitted Disease (STD) Awareness Month (April) 3
The iQ200 Automated Urinalysis System (iQ System) is a user-friendly, bench top, fully automated system that performs complete urinalyses on unspun specimens; simply load, press START and walk away....
... the C6 peptide antigen, a 26 amino acid ... peptide has been shown to represent the immunodominant ... antigenic reactivity of the whole protein. Recent ... a sensitive and specific marker for antibody to ...
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
... 3W L.E.D. is mounted coaxially on the ... lithium battery pack giving 4 hours continuous ... packs and a charging unit that can ... well as being a convenient container to ...
Medicine Products: